ChromaDex Co. (NASDAQ:CDXC) Major Shareholder Hoi Shuen Solina Holly Chau Purchases 960,000 Shares
ChromaDex Co. (NASDAQ:CDXC) Major Shareholder Hoi Shuen Solina Holly Chau Purchases 960,000 Shares
ChromaDex Co. (NASDAQ:CDXC – Get Rating) major shareholder Hoi Shuen Solina Holly Chau acquired 960,000 shares of ChromaDex stock in a transaction that occurred on Friday, September 30th. The stock was acquired at an average price of $1.25 per share, with a total value of $1,200,000.00. Following the completion of the purchase, the insider now directly owns 7,885,641 shares in the company, valued at approximately $9,857,051.25. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own more than 10% of a company's stock are required to disclose their sales and purchases with the SEC.
ChromaDex Co.(納斯達克代碼：CDXC-GET Rating)大股東海順Solina Holly Chau在9月30日(星期五)的一筆交易中收購了96萬股ChromaDex股票。該股的收購均價為每股1.25美元，總價值為1,200,000.00美元。收購完成後，該內部人士現在直接擁有該公司7,885,641股，價值約9,857,051.25美元。此次收購是在提交給美國證券交易委員會的一份文件中披露的，該文件可通過此超鏈接。持有公司10%以上股份的大股東必須披露他們在美國證券交易委員會上的銷售和購買情況。
ChromaDex Price Performance
ChromaDex性價比
CDXC stock traded up $0.06 during mid-day trading on Monday, hitting $1.29. 547 shares of the stock were exchanged, compared to its average volume of 440,557. The business has a fifty day moving average price of $1.55 and a 200 day moving average price of $1.84. ChromaDex Co. has a 12 month low of $1.15 and a 12 month high of $6.98. The stock has a market capitalization of $88.16 million, a price-to-earnings ratio of -3.15 and a beta of 1.71.
CDXC股價週一午盤上漲0.06美元，觸及1.29美元。該股成交547股，而其平均成交量為440,557股。該業務的50日移動平均價為1.55美元，200日移動平均價為1.84美元。ChromaDex Co.的12個月低點為1.15美元，12個月高位為6.98美元。該股市值為8816萬美元，市盈率為-3.15倍，貝塔係數為1.71。
ChromaDex (NASDAQ:CDXC – Get Rating) last released its earnings results on Wednesday, August 10th. The company reported ($0.09) earnings per share for the quarter, missing analysts' consensus estimates of ($0.08) by ($0.01). ChromaDex had a negative return on equity of 99.51% and a negative net margin of 41.01%. During the same period in the prior year, the company posted ($0.08) earnings per share. As a group, equities analysts forecast that ChromaDex Co. will post -0.3 EPS for the current fiscal year.
ChromaDex(納斯達克：CDXC-GET Rating)上一次發佈財報是在8月10日星期三。該公司公佈本季度每股收益為0.09美元，低於分析師普遍預期的0.08美元和0.01美元。ChromaDex的淨資產回報率為負99.51%，淨利潤率為負41.01%。去年同期，該公司公佈的每股收益為0.08美元。作為一個整體，股票分析師預計ChromaDex Co.本財年的每股收益將為0.3歐元。
Analysts Set New Price Targets
分析師設定新的價格目標
Institutional Investors Weigh In On ChromaDex
機構投資者買入ChromaDex
Institutional investors have recently made changes to their positions in the business. Tieton Capital Management LLC raised its position in ChromaDex by 242.8% in the 1st quarter. Tieton Capital Management LLC now owns 1,428,742 shares of the company's stock worth $3,515,000 after purchasing an additional 1,012,016 shares during the period. Millennium Management LLC bought a new stake in shares of ChromaDex in the 2nd quarter valued at about $1,275,000. Renaissance Technologies LLC boosted its holdings in ChromaDex by 1,004.0% during the 1st quarter. Renaissance Technologies LLC now owns 420,501 shares of the company's stock valued at $1,034,000 after acquiring an additional 382,413 shares during the period. Vanguard Group Inc. boosted its holdings in ChromaDex by 9.5% during the 1st quarter. Vanguard Group Inc. now owns 2,781,437 shares of the company's stock valued at $6,842,000 after acquiring an additional 240,414 shares during the period. Finally, GSA Capital Partners LLP bought a new position in ChromaDex during the 1st quarter worth approximately $134,000. Hedge funds and other institutional investors own 41.83% of the company's stock.
機構投資者最近對他們在該業務中的頭寸進行了調整。Tieton Capital Management LLC在第一季度將其在ChromaDex的頭寸提高了242.8%。Tieton Capital Management LLC在此期間額外購買了1,012,016股，目前擁有1,428,742股該公司股票，價值3,515,000美元。Millennium Management LLC在第二季度購買了ChromaDex的新股，價值約1,275,000美元。復興科技有限責任公司在第一季度將其在ChromaDex的持股增加了1004.0%。復興科技有限責任公司在此期間增持了382,413股，目前擁有420,501股該公司股票，價值1,034,000美元。先鋒集團第一季度增持ChromaDex 9.5%的股份。先鋒集團在此期間增持了240,414股，目前持有2,781,437股該公司股票，價值6,842,000美元。最後，GSA Capital Partners LLP在第一季度購買了ChromaDex的一個新頭寸，價值約13.4萬美元。對衝基金和其他機構投資者持有該公司41.83%的股票。
ChromaDex Company Profile
ChromaDex公司簡介
(Get Rating)
(獲取評級)
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products.
ChromaDex公司是一家專注於健康老齡化的生物科學公司。該公司通過三個部門運營：消費品；配料；以及分析參考標準和服務。它研究煙酰胺腺嘌呤二核苷酸(NAD+)；直接向消費者和經銷商提供含有其專利成分的成品膳食補充劑產品；開發基於專利的成分技術並將其商業化，並將這些成分作為原材料供應給消費品製造商。
Featured Articles
專題文章
- Get a free copy of the StockNews.com research report on ChromaDex (CDXC)
- Near-Term Headwinds Send Nike To The Bargain Basement
- Archer Daniels Midland: Dividend Hero With 49 Years Of Increases
- Will Fully Autonomous Tractors Make Deere the Tesla of Farming?
- Magna International is Your Auto and EV One-Stop Shop Stock
- Is the Bond Market Signaling a Market Bottom?
- 免費獲取StockNews.com在ChromaDex(CDXC)上的研究報告
- 近期的逆風將耐克送到了廉價地下室
- 阿徹·丹尼爾斯·米德蘭：49年增長的紅利英雄
- 全自動拖拉機會讓迪爾成為農業領域的特斯拉嗎？
- 麥格納國際是您的汽車和電動汽車一站式庫存
- 債券市場是否發出了市場觸底的信號？
Receive News & Ratings for ChromaDex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ChromaDex and related companies with MarketBeat.com's FREE daily email newsletter.
接受ChromaDex Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對ChromaDex和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。